Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Multiomics Tumor Evolution Model of NSCLC
A multiomics study exploring tumor evolution in non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Integrin αvβ6-targeted PET in Malignant Tumors
A recruiting clinical trial evaluating an integrin αvβ6-targeted PET tracer for imaging malignant tumors, including non-small cell lung canc…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating Sutetinib Maleate Capsule for locally advanced or metastatic non-small cell lung cancer; recruitment is cu…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy) [Phase 2]
Phase 2 clinical trial update for Zenocutuzumab (MCLA-128) in solid tumors harboring NRG1 fusions, including non-small cell lung cancer and …
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: Comparison of Neoadjuvant Cadonilimab Versus Chemotherapy Combined With PD-1 in the Treatment of Resectable Non-Small Cell Lung Cancer With High PD-L1 Expression: A Single-Center, Randomized, Exploratory Clinical Study [Phase 2]
A Phase 2, single-center randomized exploratory trial comparing neoadjuvant Cadonilimab versus chemotherapy with a PD-1 inhibitor in resecta…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: A Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China
Clinical trial update for a real-world study in China assessing treatment of leptomeningeal metastasis from non-small cell lung cancer; the …
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression [Phase 1, Phase 2]
A2 Biotherapeutics is evaluating A2B530, a logic-gated CAR T therapy, in Phase 1/2 trials for CEA-expressing solid tumors that have lost HLA…
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: A Clinical Trial of Furmonertinib Combined With Anlotinib as First-line Treatment for Advanced NSCLC With EGFR-sensitive Mutations and Brain Metastasis [Phase 2]
Phase 2 clinical trial evaluating furmonertinib in combination with anlotinib as first-line therapy for advanced non-small cell lung cancer …
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Study of NEO-201 in Solid Tumors Expansion Cohorts [Phase 1, Phase 2]
Precision Biologics is expanding cohorts in a Phase 1/2 study of NEO-201 in solid tumors, including non-small cell lung cancer, head and nec…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: A Pilot Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) in Central Non-Small Cell Lung Cancer [NA]
This clinical trial update notes a pilot study evaluating single-fraction stereotactic body radiation therapy (SBRT) for central non-small c…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors [Phase 1]
Phase 1 trial update studying the immune effects of a fermented wheat germ extract added to standard checkpoint inhibitor therapy in patient…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Exploration of Risk Factors for Postoperative Cerebral Infarction in Lung Cancer Patients: a Retrospective Single-centre Study
A retrospective, single-centre study examining risk factors for postoperative cerebral infarction in patients with non-small cell lung cance…
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 clinical trial is evaluating PLB1004, an oral EGFR inhibitor, in patients with non-small cell lung cancer and is currently recruit…
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: A Study to Compare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Lung Cancer [Phase 3]
A Phase 3 trial evaluating CT-P51 versus pembrolizumab (Keytruda) in patients with previously untreated metastatic non-small cell lung cance…
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: Evaluate Safety and Tolerability of RX001 in Patients With KRAS Mutant Advanced NSCLC [Phase 1]
A Phase 1 trial is evaluating the safety and tolerability of RX001 in patients with KRAS-mutant advanced non-small cell lung cancer; the stu…
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC
This clinical trial update describes a study using circulating tumor DNA analysis to monitor the risk of disease progression after first-lin…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Neoadjuvant Nivolumab Plus Ipilimumab in Resectable NSCLC (GALAXY 3) [Phase 2]
Phase 2 GALAXY 3 trial assessing neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer; currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Prehabilitation for Patients Undergoing Lung Cancer Surgery [NA]
A clinical trial evaluating prehabilitation before lung cancer surgery in patients with non-small cell lung cancer; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Development of New Methodologies and Innovative Tools for the diagnoSi and Therapeutic Treatment of uMAni Epithelial Tumors
A recruiting clinical trial update from ASL Lecce on developing new methodologies and innovative tools for diagnosing and treating human epi…
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: A Multicenter, Single-arm Phase II Study to Evaluate the Efficacy and Safety of Fulzerasib (IBI351) in Combination With Ivonescimab (AK-112) in First-line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer Patients With KRAS G12C Mutation [Phase 2]
Phase II multicenter single-arm study evaluating Fulzerasib (IBI351) in combination with Ivonescimab (AK-112) as first-line treatment for ad…
-
CLINICAL_TRIALS research · 2025-04-18Clinical Trial Update: Hippocampus-Avoidance Whole-Brain Radiation Therapy With Simultaneous Integrated Boost for BMs of NSCLC [NA]
Clinical trial update on hippocampus-avoidance whole-brain radiation therapy with simultaneous integrated boost for brain metastases from no…
-
CLINICAL_TRIALS research · 2025-04-18Clinical Trial Update: Machine Learning Approaches to Personalized Therapy for Advanced Non-small Cell Lung Cancer With Real-World Data
A clinical trial from the University of Utah is exploring machine learning methods to tailor therapy for advanced non-small cell lung cancer…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: A Study of DM001 in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial evaluating DM001 in patients with advanced solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLC [Phase 1, Phase 2]
This clinical trial update reports that SHR-1826 is being studied in combination with other antitumor therapies for non-small cell lung canc…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: A Randomized Pilot Study of Evolocumab Plus Nivolumab/Ipilimumab in Treatment-Naïve Patients With Metastatic NSCLC [Phase 2]
A Phase 2 randomized pilot trial is investigating evolocumab in combination with nivolumab/ipilimumab for treatment-naïve metastatic non-sma…